PRM171 Cognitive testing of the investigator's global assessment of lateral canthal lines (IGA-LCL) severity scale  by Turner-Bowker, D.M. et al.
A44 V A L U E  I N  H E A L T H  1 6  ( 2 0 1 3 )  A 1 - A 2 9 8  
  
 
acceptable reliability and good validity, which could be used to assess angina 
self-management, and also recommended to be used as an outcome along with 
quality of life to assess clinical efficacy. The risk-factor domain would be 
modified in the further study.  
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OBJECTIVES: Fatigue is the main symptom of anemia. A blood transfusion is 
often necessary in patients with severe anemia, and fatigue will be released after 
the transfusion. However, patients with chronic anemia are often well tolerated, 
and do not feel the severe fatigue that is expected. So, how much is fatigue 
associated with anemia, and what’s the main impact influencing anemic 
fatigue? METHODS: Patients diagnosed with CAA or MDS-RA were recruited in 
an undergoing prospective observational study. Fatigue was assessed by the 
FACIT-Fatigue scale, and a higher score means better quality of life. All the 
patients filled in the Fatigue scale and ran blood tests on the day enrolled, and 
they were encouraged to be assessed by both Fatigue scale and blood test again a 
week later. The patients were divided into groups based on transfusion-
dependent, transfusion treatment, anemia level (severe<65g/L), fatigue level 
(severe<30). Chi-square or T-tests were performed between different groups. 
Pearson correlations were tested to investigate association between fatigue and 
all the possible factors. RESULTS: Thirty-eight patients (54±18 years, 12 male) 
enrolled, of those, 20 were transfusion-dependent, 14 had severe anemia, and 26 
felt severe fatigue. The anemia history was 54±78 months (median 15). 
Transfusion-dependent patients showed no difference in fatigue. Severe anemia 
patients (22±11) reported more fatigue than non-severe (27±11), but no difference 
(p=0.199). Twenty patients agreed to the reassessment; of those, 12 got 
transfusion treatment. After transfusion, the mean Hb level increased (11±8 g/L), 
and fatigue improved (8±10); as for the non-transfusion group, Hb changed (-4±13 
g/L), and fatigue changed (0±16). However, there was no difference between the 
two groups (p>0.05). Anemia history was related with fatigue (r=-0.351, p=0.031) 
and transfusion frequency (r=-0.617, p=0.001). CONCLUSIONS: Fatigue is not 
closely associated with degree of Hb and is well tolerated in chronic anemia 
patient. RBC transfusion can relieve fatigue, but a large sample is needed to 
confirm it.  
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OBJECTIVES: To compare the preference values for EQ-5D-5L health states 
between mainland Chinese and Singaporeans. METHODS: Data was from a 
multi-country health-state valuation study in which the preference values for 10 
selected EQ-5D-5L health states were elicited from a convenience sample of 
mainland Chinese in Beijing (China) as well as a convenience sample of 
Singaporeans. Each participant self-completed 5 time trade-off (TTO) tasks, each 
for a different EQ-5D-5L state, using a personal computer. The difference in TTO 
values between mainland Chinese and Singaporeans and three subgroups of 
Singaporeans (i.e. English-speaking Chinese [EC], Chinese-speaking Chinese [CC], 
and non-Chinese [NC]) was analyzed using random-effects linear regression and 
logistic regression models. RESULTS: A total of 210 mainland Chinese and 207 
Singaporeans provided data for this study. All 10 EQ-5D-5L health states 
considered, Singaporeans’ preference value was 0.146 points lower than that of 
mainland Chinese and the difference was consistent for all three subgroups of 
Singaporeans (EC: -0.156; CC: -0.195; NC: -0.073; p>0.05 for all comparisons), 
suggesting those health states were less valuable to Singaporeans than to 
mainland Chinese. Compare to mainland Chinese, Singaporeans were more 
likely to consider a health state as worse than being dead and consequently have 
a negative value to the state; the odds ratio (95% confidence interval) was 
1.31(0.54-3.53) for Singaporeans as a whole, 1.41(0.60-3.33) for EC, 1.35(0.49-3.70) 
for CC, and 1.11(0.50-3.13) for NC. For health states rated as worse than being 
dead, Singaporeans had substantial lower preference values than mainland 
Chinese, with the magnitude of difference being 0.399 for all, 0.383 for EC, 0.377 
for CC, and 0.456 for NC (P<0.05 for all comparisons). CONCLUSIONS: It appears 
that health-state preferences differ between mainland Chinese and 
Singaporeans including Singaporean Chinese. Our study supports the practice of 
developing country-specific value sets for EQ-5D-5L health states.  
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OBJECTIVES: To evaluate clinicians’ ability to understand and respond to the 
IGA-LCL, a single item severity rating scale of LCLs at neutral facial position. 
METHODS: Individual face-to-face cognitive interviews were conducted with 
seven dermatologists and one plastic surgeon from the US with experience in 
aesthetic medicine including treating LCLs. Participants attended one of two 
research sessions. At each session, the participant group received training on the 
IGA-LCL, consistent with the training provided for clinicians in phase 3 trials 
using the IGA-LCL. Two researchers then conducted individual semi-structured 
interviews with participants, following a process that required them to “think 
aloud” while reading response options and formulating a response. Interviews 
were audio-recorded and transcribed. Analyses summarized participant 
feedback on the instrument. RESULTS: Overall, findings indicate that the IGA-
LCL scale is clear and easy to use. Clinicians understood the content and were 
able to use the response options as intended. No revisions to the IGA-LCL scale 
were recommended based on results from this study, though training topics 
were identified for further emphasis and clarification. A few participants 
suggested alternate text for some response descriptions though these same 
participants understood and could use the descriptions as currently stated. One 
participant noted that she might arbitrarily define the descriptions differently 
based on her clinical experience and noted the subjectivity in making a clinical 
judgment of LCL severity, but understood and could use the IGA-LCL 
appropriately based on the training. Two participants indicated that they usually 
think about the “worst” length of wrinkle, but they could rate “average” length as 
instructed in the training. Most participants stressed the importance of training 
for proper use of the scale. CONCLUSIONS: Results support the content validity 
of the IGA-LCL. This research represents an important step toward establishing 
the content validity of the IGA-LCL relative to the FDA PRO Guidance.  
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OBJECTIVES: To describe the qualitative development of corresponding self-
reported and observer reported scales for assessing spasticity-related pain (SRP) 
experienced by children with Cerebral Palsy (CP). METHODS: The Questionnaire 
on Pain Caused by Spasticity (QPS) is a newly developed clinical outcome 
measure designed to assess SRP using corresponding versions that can be self-
administered by children (5-10 years), adolescents (11-17 years), and by parent 
caregivers (as observers of signs of pain in their children). Cognitive interviews 
were conducted to confirm appropriate understanding and the ability of children 
of various ages and CP severity to provide meaningful responses. RESULTS: Two 
children, eight adolescents, and 11 parent/caregivers participated in the 
interview sessions. Parent/caregivers were able to work with their children to 
collectively identify the location of their SRP. Children age 7 and above who 
could read and had sufficient motor skills for independently self-administering a 
questionnaire could answer questions about pain severity in relation to specific 
activities, but were not able to reliably address the frequency or duration of their 
pain. Children 5-7 years (and those with more severe CP) who were able to 
communicate answered the same items but in interviewer-administered format. 
Parent/caregivers could report on observed signs of pain in their children but not 
address the subjective intensity of that pain. They could, however, report on the 
frequency of those signs of pain. Because direct attention and close contact time 
between parent/caregivers and children with CP varies, parent/caregiver 
observations of the duration of pain was less reliable. CONCLUSIONS: Direct 
correspondence of items addressing key concepts (e.g. presence of SRP) can 
provide an anchor for combining patient reported and observer reported 
information and relating the various descriptive aspects around the concepts 
being measured to provide a more complete and richer dataset for compromised 
populations where assessment is challenging.  
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OBJECTIVES: To develop a patient-reported outcome (PRO) measure to assess the 
key symptoms of chronic low back pain (cLBP) through qualitative concept 
elicitation (CE) and cognitive interviews. METHODS: Adult patients (18-80 years) 
with clinical diagnoses of cLBP of non-malignant origin and current pain scores 
≥4 on a 0-10 numerical rating scale (NRS) were recruited in the U.S., UK, and 
Germany. Trained interviewers conducted CE and cognitive interview sessions 
with participating patients using semi-structured interview guides. The CE 
interviews elicited spontaneous reports of symptom experiences followed by 
probing to further explore and confirm concepts. The cognitive interviews 
evaluated the degree of patient comprehension of the items in the draft PRO 
measure. All interview sessions were audio recorded and transcribed. The CE 
interviews were coded for qualitative content analysis using Atlas.ti, and the 
cognitive interview transcripts were summarized in cognitive report tables. 
RESULTS: Forty-three CE interviews were conducted (mean age: 48.6±13.0, 53.5% 
female, 74.4% -White/Caucasian). Mean pain NRS score was 6.7± 1.3. A total of 
1342 symptom codes were derived from the transcripts, representing 32 different 
symptom concepts. Data from CE interviews was considered alongside existing 
measures, published literature and expert opinion to develop a 23-item draft 
measure. Thirty additional patients participated in four waves of cognitive 
interviews, during which nine items were removed and others were 
substantially modified to create the Pain Assessment for Low Back Symptoms 
(PAL-S). CONCLUSIONS: The PAL-S is a 14-item PRO measure for assessing 
symptoms of cLBP that has been developed through direct qualitative patient 
involvement in accordance with the FDA’s PRO Guidance and scientific best 
practices. Cognitive interviews have provided evidence from patients that the 
measure is comprehensive, relevant to their cLBP experience, comprehendible, 
